世界の淋病診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gonorrhea Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2609 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、淋病診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（クロマトグラフィー、画像診断、微分光散乱、フローサイトメトリー、ゲル微小液滴、イムノアッセイ、分子診断、モノクローナル抗体検査）、用途別市場規模（病院、外来手術センター、診断センター、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・淋病診断の市場動向 ・企業の競争状況、市場シェア ・淋病診断の種類別市場規模（クロマトグラフィー、画像診断、微分光散乱、フローサイトメトリー、ゲル微小液滴、イムノアッセイ、分子診断、モノクローナル抗体検査） ・淋病診断の用途別市場規模（病院、外来手術センター、診断センター、クリニック、その他） ・淋病診断の北米市場規模2016-2027（アメリカ、カナダ） ・淋病診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・淋病診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・淋病診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・淋病診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Beckman Coulter、Roche Diagnostics、Siemens、bioMérieux、PerkinElmer、Ortho Clinical Diagnostics） ・結論

Gonorrhea is a sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae and can affect both genders. It is a common infection, especially among young people aged between 15 years to 24 years. According to the U.S. Centers for Disease Control and Prevention (CDC), gonorrhea is the second most commonly reported disease in the United States affecting approximately 800,000 people each year. In the United Kingdom, about 28,000 cases of gonorrhea are reported each year. Symptoms of gonorrhea in men encompass painful urination, swelling of testicles and pus discharge. In women, symptoms comprise excessive vaginal discharge, painful urination and abdominal pain. Complications include ectopic pregnancy, Pelvic Inflammatory Disease (PID) and Epididymitis. The incubation period for this disease also varies between men and women. In men, the symptoms occur between 2 to 14 days whereas in women it takes 7 days to 21 days to show symptoms. Astonishingly, about 50% of women have no symptoms in the early stage and during pregnancy it may infect the fetus during delivery.
There has been a recent rise in the incidences of gonorrhea across the globe due to the adoption of risky sexual behavior and unsafe sexual practices. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. The highest occurrence rates of gonorrhea are primarily in heterosexually infected men, especially those aged 25-34 years. These increasing incidences of gonorrhea will enhance the demand for gonorrhea diagnostic products during the forecast period.

Market Analysis and Insights: Global Gonorrhea Diagnostics Market
The global Gonorrhea Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gonorrhea Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gonorrhea Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gonorrhea Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gonorrhea Diagnostics market.

Global Gonorrhea Diagnostics Scope and Market Size
Gonorrhea Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gonorrhea Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chromatography
Diagnostic Imaging
Differential Light Scattering
Flow Cytometry
Gel Microdroplets
Immunoassay
Molecular Diagnostics
Monoclonal Antibodies Test

Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Beckman Coulter
Roche Diagnostics
Siemens
bioMérieux
PerkinElmer
Ortho Clinical Diagnostics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gonorrhea Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chromatography
1.2.3 Diagnostic Imaging
1.2.4 Differential Light Scattering
1.2.5 Flow Cytometry
1.2.6 Gel Microdroplets
1.2.7 Immunoassay
1.2.8 Molecular Diagnostics
1.2.9 Monoclonal Antibodies Test
1.3 Market by Application
1.3.1 Global Gonorrhea Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Clinics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gonorrhea Diagnostics Market Perspective (2016-2027)
2.2 Gonorrhea Diagnostics Growth Trends by Regions
2.2.1 Gonorrhea Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gonorrhea Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Gonorrhea Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Gonorrhea Diagnostics Industry Dynamic
2.3.1 Gonorrhea Diagnostics Market Trends
2.3.2 Gonorrhea Diagnostics Market Drivers
2.3.3 Gonorrhea Diagnostics Market Challenges
2.3.4 Gonorrhea Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gonorrhea Diagnostics Players by Revenue
3.1.1 Global Top Gonorrhea Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Gonorrhea Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Gonorrhea Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gonorrhea Diagnostics Revenue
3.4 Global Gonorrhea Diagnostics Market Concentration Ratio
3.4.1 Global Gonorrhea Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gonorrhea Diagnostics Revenue in 2020
3.5 Gonorrhea Diagnostics Key Players Head office and Area Served
3.6 Key Players Gonorrhea Diagnostics Product Solution and Service
3.7 Date of Enter into Gonorrhea Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gonorrhea Diagnostics Breakdown Data by Type
4.1 Global Gonorrhea Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Gonorrhea Diagnostics Forecasted Market Size by Type (2022-2027)

5 Gonorrhea Diagnostics Breakdown Data by Application
5.1 Global Gonorrhea Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Gonorrhea Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gonorrhea Diagnostics Market Size (2016-2027)
6.2 North America Gonorrhea Diagnostics Market Size by Type
6.2.1 North America Gonorrhea Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Gonorrhea Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Gonorrhea Diagnostics Market Size by Type (2016-2027)
6.3 North America Gonorrhea Diagnostics Market Size by Application
6.3.1 North America Gonorrhea Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Gonorrhea Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Gonorrhea Diagnostics Market Size by Application (2016-2027)
6.4 North America Gonorrhea Diagnostics Market Size by Country
6.4.1 North America Gonorrhea Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Gonorrhea Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Gonorrhea Diagnostics Market Size (2016-2027)
7.2 Europe Gonorrhea Diagnostics Market Size by Type
7.2.1 Europe Gonorrhea Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Gonorrhea Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Gonorrhea Diagnostics Market Size by Type (2016-2027)
7.3 Europe Gonorrhea Diagnostics Market Size by Application
7.3.1 Europe Gonorrhea Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Gonorrhea Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Gonorrhea Diagnostics Market Size by Application (2016-2027)
7.4 Europe Gonorrhea Diagnostics Market Size by Country
7.4.1 Europe Gonorrhea Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Gonorrhea Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gonorrhea Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Gonorrhea Diagnostics Market Size by Type
8.2.1 Asia-Pacific Gonorrhea Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gonorrhea Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gonorrhea Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Gonorrhea Diagnostics Market Size by Application
8.3.1 Asia-Pacific Gonorrhea Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gonorrhea Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gonorrhea Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Gonorrhea Diagnostics Market Size by Region
8.4.1 Asia-Pacific Gonorrhea Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gonorrhea Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gonorrhea Diagnostics Market Size (2016-2027)
9.2 Latin America Gonorrhea Diagnostics Market Size by Type
9.2.1 Latin America Gonorrhea Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Gonorrhea Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Gonorrhea Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Gonorrhea Diagnostics Market Size by Application
9.3.1 Latin America Gonorrhea Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Gonorrhea Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Gonorrhea Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Gonorrhea Diagnostics Market Size by Country
9.4.1 Latin America Gonorrhea Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Gonorrhea Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gonorrhea Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Gonorrhea Diagnostics Market Size by Type
10.2.1 Middle East & Africa Gonorrhea Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gonorrhea Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gonorrhea Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Gonorrhea Diagnostics Market Size by Application
10.3.1 Middle East & Africa Gonorrhea Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gonorrhea Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gonorrhea Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Gonorrhea Diagnostics Market Size by Country
10.4.1 Middle East & Africa Gonorrhea Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gonorrhea Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Gonorrhea Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Gonorrhea Diagnostics Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Gonorrhea Diagnostics Introduction
11.2.4 Beckman Coulter Revenue in Gonorrhea Diagnostics Business (2016-2021)
11.2.5 Beckman Coulter Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Details
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Gonorrhea Diagnostics Introduction
11.3.4 Roche Diagnostics Revenue in Gonorrhea Diagnostics Business (2016-2021)
11.3.5 Roche Diagnostics Recent Development
11.4 Siemens
11.4.1 Siemens Company Details
11.4.2 Siemens Business Overview
11.4.3 Siemens Gonorrhea Diagnostics Introduction
11.4.4 Siemens Revenue in Gonorrhea Diagnostics Business (2016-2021)
11.4.5 Siemens Recent Development
11.5 bioMérieux
11.5.1 bioMérieux Company Details
11.5.2 bioMérieux Business Overview
11.5.3 bioMérieux Gonorrhea Diagnostics Introduction
11.5.4 bioMérieux Revenue in Gonorrhea Diagnostics Business (2016-2021)
11.5.5 bioMérieux Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Details
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer Gonorrhea Diagnostics Introduction
11.6.4 PerkinElmer Revenue in Gonorrhea Diagnostics Business (2016-2021)
11.6.5 PerkinElmer Recent Development
11.7 Ortho Clinical Diagnostics
11.7.1 Ortho Clinical Diagnostics Company Details
11.7.2 Ortho Clinical Diagnostics Business Overview
11.7.3 Ortho Clinical Diagnostics Gonorrhea Diagnostics Introduction
11.7.4 Ortho Clinical Diagnostics Revenue in Gonorrhea Diagnostics Business (2016-2021)
11.7.5 Ortho Clinical Diagnostics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gonorrhea Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chromatography
Table 3. Key Players of Diagnostic Imaging
Table 4. Key Players of Differential Light Scattering
Table 5. Key Players of Flow Cytometry
Table 6. Key Players of Gel Microdroplets
Table 7. Key Players of Immunoassay
Table 8. Key Players of Molecular Diagnostics
Table 9. Key Players of Monoclonal Antibodies Test
Table 10. Global Gonorrhea Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Gonorrhea Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Gonorrhea Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Gonorrhea Diagnostics Market Share by Regions (2016-2021)
Table 14. Global Gonorrhea Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Gonorrhea Diagnostics Market Share by Regions (2022-2027)
Table 16. Gonorrhea Diagnostics Market Trends
Table 17. Gonorrhea Diagnostics Market Drivers
Table 18. Gonorrhea Diagnostics Market Challenges
Table 19. Gonorrhea Diagnostics Market Restraints
Table 20. Global Gonorrhea Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Gonorrhea Diagnostics Market Share by Players (2016-2021)
Table 22. Global Top Gonorrhea Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gonorrhea Diagnostics as of 2020)
Table 23. Ranking of Global Top Gonorrhea Diagnostics Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Gonorrhea Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Gonorrhea Diagnostics Product Solution and Service
Table 27. Date of Enter into Gonorrhea Diagnostics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Gonorrhea Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Gonorrhea Diagnostics Revenue Market Share by Type (2016-2021)
Table 31. Global Gonorrhea Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Gonorrhea Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Gonorrhea Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Gonorrhea Diagnostics Revenue Market Share by Application (2016-2021)
Table 35. Global Gonorrhea Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Gonorrhea Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Gonorrhea Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Gonorrhea Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Gonorrhea Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Gonorrhea Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Gonorrhea Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Gonorrhea Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Gonorrhea Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Gonorrhea Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Gonorrhea Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Gonorrhea Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Gonorrhea Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Gonorrhea Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Gonorrhea Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Gonorrhea Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Gonorrhea Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Gonorrhea Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Gonorrhea Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Gonorrhea Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Gonorrhea Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Gonorrhea Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Gonorrhea Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Gonorrhea Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Gonorrhea Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Gonorrhea Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Gonorrhea Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Gonorrhea Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Gonorrhea Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Gonorrhea Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Gonorrhea Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Gonorrhea Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 67. Abbott Laboratories Company Details
Table 68. Abbott Laboratories Business Overview
Table 69. Abbott Laboratories Gonorrhea Diagnostics Product
Table 70. Abbott Laboratories Revenue in Gonorrhea Diagnostics Business (2016-2021) & (US$ Million)
Table 71. Abbott Laboratories Recent Development
Table 72. Beckman Coulter Company Details
Table 73. Beckman Coulter Business Overview
Table 74. Beckman Coulter Gonorrhea Diagnostics Product
Table 75. Beckman Coulter Revenue in Gonorrhea Diagnostics Business (2016-2021) & (US$ Million)
Table 76. Beckman Coulter Recent Development
Table 77. Roche Diagnostics Company Details
Table 78. Roche Diagnostics Business Overview
Table 79. Roche Diagnostics Gonorrhea Diagnostics Product
Table 80. Roche Diagnostics Revenue in Gonorrhea Diagnostics Business (2016-2021) & (US$ Million)
Table 81. Roche Diagnostics Recent Development
Table 82. Siemens Company Details
Table 83. Siemens Business Overview
Table 84. Siemens Gonorrhea Diagnostics Product
Table 85. Siemens Revenue in Gonorrhea Diagnostics Business (2016-2021) & (US$ Million)
Table 86. Siemens Recent Development
Table 87. bioMérieux Company Details
Table 88. bioMérieux Business Overview
Table 89. bioMérieux Gonorrhea Diagnostics Product
Table 90. bioMérieux Revenue in Gonorrhea Diagnostics Business (2016-2021) & (US$ Million)
Table 91. bioMérieux Recent Development
Table 92. PerkinElmer Company Details
Table 93. PerkinElmer Business Overview
Table 94. PerkinElmer Gonorrhea Diagnostics Product
Table 95. PerkinElmer Revenue in Gonorrhea Diagnostics Business (2016-2021) & (US$ Million)
Table 96. PerkinElmer Recent Development
Table 97. Ortho Clinical Diagnostics Company Details
Table 98. Ortho Clinical Diagnostics Business Overview
Table 99. Ortho Clinical Diagnostics Gonorrhea Diagnostics Product
Table 100. Ortho Clinical Diagnostics Revenue in Gonorrhea Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Ortho Clinical Diagnostics Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gonorrhea Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Chromatography Features
Figure 3. Diagnostic Imaging Features
Figure 4. Differential Light Scattering Features
Figure 5. Flow Cytometry Features
Figure 6. Gel Microdroplets Features
Figure 7. Immunoassay Features
Figure 8. Molecular Diagnostics Features
Figure 9. Monoclonal Antibodies Test Features
Figure 10. Global Gonorrhea Diagnostics Market Share by Application: 2020 VS 2027
Figure 11. Hospitals Case Studies
Figure 12. Ambulatory Surgical Centers Case Studies
Figure 13. Diagnostic Centers Case Studies
Figure 14. Clinics Case Studies
Figure 15. Others Case Studies
Figure 16. Gonorrhea Diagnostics Report Years Considered
Figure 17. Global Gonorrhea Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Gonorrhea Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Gonorrhea Diagnostics Market Share by Regions: 2020 VS 2027
Figure 20. Global Gonorrhea Diagnostics Market Share by Regions (2022-2027)
Figure 21. Global Gonorrhea Diagnostics Market Share by Players in 2020
Figure 22. Global Top Gonorrhea Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gonorrhea Diagnostics as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Gonorrhea Diagnostics Revenue in 2020
Figure 24. Global Gonorrhea Diagnostics Revenue Market Share by Type (2016-2021)
Figure 25. Global Gonorrhea Diagnostics Revenue Market Share by Type (2022-2027)
Figure 26. North America Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Gonorrhea Diagnostics Market Share by Type (2016-2027)
Figure 28. North America Gonorrhea Diagnostics Market Share by Application (2016-2027)
Figure 29. North America Gonorrhea Diagnostics Market Share by Country (2016-2027)
Figure 30. United States Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Gonorrhea Diagnostics Market Share by Type (2016-2027)
Figure 34. Europe Gonorrhea Diagnostics Market Share by Application (2016-2027)
Figure 35. Europe Gonorrhea Diagnostics Market Share by Country (2016-2027)
Figure 36. Germany Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Gonorrhea Diagnostics Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Gonorrhea Diagnostics Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Gonorrhea Diagnostics Market Share by Region (2016-2027)
Figure 46. China Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Gonorrhea Diagnostics Market Share by Type (2016-2027)
Figure 54. Latin America Gonorrhea Diagnostics Market Share by Application (2016-2027)
Figure 55. Latin America Gonorrhea Diagnostics Market Share by Country (2016-2027)
Figure 56. Mexico Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Gonorrhea Diagnostics Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Gonorrhea Diagnostics Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Gonorrhea Diagnostics Market Share by Country (2016-2027)
Figure 62. Turkey Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Gonorrhea Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Abbott Laboratories Revenue Growth Rate in Gonorrhea Diagnostics Business (2016-2021)
Figure 66. Beckman Coulter Revenue Growth Rate in Gonorrhea Diagnostics Business (2016-2021)
Figure 67. Roche Diagnostics Revenue Growth Rate in Gonorrhea Diagnostics Business (2016-2021)
Figure 68. Siemens Revenue Growth Rate in Gonorrhea Diagnostics Business (2016-2021)
Figure 69. bioMérieux Revenue Growth Rate in Gonorrhea Diagnostics Business (2016-2021)
Figure 70. PerkinElmer Revenue Growth Rate in Gonorrhea Diagnostics Business (2016-2021)
Figure 71. Ortho Clinical Diagnostics Revenue Growth Rate in Gonorrhea Diagnostics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---